The most commonly reported side effects are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal pain
It sells only FDA-approved brand-name GLP-1 drugs and pairs them with a separate membership fee
These results highlight the efficacy of tirzepatide in improving lipid metabolism, in addition to the glycemic control and weight loss benefits emphasized by previous reviews
Klinic aids in evaluating eligibility
In the STEP trials, approximately 3% of participants reported hair loss
In the import alert text, FDA describes evaluating 48 GLP1 API sites via onsite inspections and remote assessments, and says 21% were found noncompliant under section 501 of the FD&C Act, either due to evidence of CGMP noncompliance or because firms didnt respond to FDAs records requests in time